JL
Jupiter Life Line Hospitals Limited
JLHL.BO · BSE
₹278.70 -0.66% (-₹1.85)
1M -8.24%
Market Cap ₹91.9B
P/E Ratio 48.96x
Div. Yield 0.36%
ROE 13.16%
Bulios Fair Price
₹212.28
23.8% downside
Current Price
₹278.7
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JLHL.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
7 /100
Expensive PEG 92.40x
P/E 48.96x
P/B 5.95x
Growth
100 /100
Growing Book val. growth 61.63%
EPS growth 31.71%
Rev. growth 18.89%
Profitability
55 /100
Moderate Op. margin 16.13%
Gross margin 63.17%
FCF margin 2.59%
Quality
57 /100
Average ROA 7.88%
ROIC 8.70%
Asset turnover 0.65x
Debt
84 /100
Low Int. coverage 7.41x
Debt/Equity 0.38x
Net debt/EBITDA 1.43x
Stability
47 /100
Moderate EPS volatility 67.92%
Beta 0.19x
Profitable years 5
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JLHL.BO
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Ankit Ajay Thakker
Employees
3,002
Headquarters
Mumbai
Upcoming events
06 NOV
Earnings
Upcoming earnings report